American Journal of Medicine and Medical Sciences
p-ISSN: 2165-901X e-ISSN: 2165-9036
2026; 16(1): 268-274
doi:10.5923/j.ajmms.20261601.59
Received: Nov. 29, 2025; Accepted: Dec. 17, 2025; Published: Jan. 22, 2026

Muxitdinov Shaxrizod Muxiddinovich1, Xaydarov Nodir Qobilovich2, Azimov Aziz Muhammadjonovich3, Nigmatova Iroda Maratovna4
1Independent Researcher, Tashkent State Medical University, Department of Oral Surgery and Dental Implantology, Tashkent City, Uzbekistan
2Head of the Department of Neurology and Folk Medicine, Professor, Tashkent City, Uzbekistan
3Head of the Department of Oral Surgery and Dental Implantology, Professor, Tashkent City, Uzbekistan
4DcS, Tashkent State Medical University, Department of Orthodontics, Tashkent City, Uzbekistan
Correspondence to: Muxitdinov Shaxrizod Muxiddinovich, Independent Researcher, Tashkent State Medical University, Department of Oral Surgery and Dental Implantology, Tashkent City, Uzbekistan.
| Email: | ![]() |
Copyright © 2026 The Author(s). Published by Scientific & Academic Publishing.
This work is licensed under the Creative Commons Attribution International License (CC BY).
http://creativecommons.org/licenses/by/4.0/

This comprehensive review examines the specific clinical considerations and evidence-based protocols necessary for safe and effective oral surgical interventions in patients diagnosed with epilepsy. The study synthesizes current literature on perioperative management, pharmacological interactions, and complication prevention strategies. A systematic literature review was conducted encompassing publications from 2003-2024 across PubMed, Scopus, Web of Science, and Cochrane databases. Search terms included epilepsy, oral surgery, dental management, antiepileptic drugs, and seizure disorders. Inclusion criteria focused on clinical studies, systematic reviews, and evidence-based guidelines pertaining to oral surgical care in epileptic populations. Patients with epilepsy present unique challenges in oral surgical settings, including elevated risks of seizure occurrence during procedures, significant drug interactions between antiepileptic medications and dental therapeutics, and distinct oral manifestations secondary to prolonged antiepileptic drug (AED) therapy. Phenytoin induces gingival hyperplasia in approximately 50% of patients undergoing long-term treatment, necessitating specialized surgical interventions. Approximately 20 to 30% of epilepsy patients demonstrate refractory responses to current antiepileptic medications and continue experiencing seizures, requiring heightened perioperative vigilance. Evidence indicates that meticulous preoperative assessment, appropriate scheduling strategies, stress reduction protocols, and comprehensive emergency preparedness significantly minimize intraoperative complications.
Keywords: Epilepsy, Oral surgery, Antiepileptic drugs, Seizure management, Dental care, Gingival hyperplasia, Perioperative management
Cite this paper: Muxitdinov Shaxrizod Muxiddinovich, Xaydarov Nodir Qobilovich, Azimov Aziz Muhammadjonovich, Nigmatova Iroda Maratovna, A Review of Oral Surgical Management in Patients with Epilepsy, American Journal of Medicine and Medical Sciences, Vol. 16 No. 1, 2026, pp. 268-274. doi: 10.5923/j.ajmms.20261601.59.